Detalles de la búsqueda
1.
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study.
Endocr Relat Cancer
; 15(2): 583-96, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18509006
2.
Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.
Clin Ther
; 28(10): 1485-508, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17157109
3.
Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.
J Clin Endocrinol Metab
; 88(11): 5414-21, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14602782
4.
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.
Am J Physiol Endocrinol Metab
; 289(6): E1044-50, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16046458
Resultados
1 -
4
de 4
1
Próxima >
>>